Status:
COMPLETED
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Lead Sponsor:
Vanda Pharmaceuticals
Conditions:
Motion Sickness
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in subjects affected by motion sickness during travel
Eligibility Criteria
Inclusion
- History of motion sickness
- Age 18-75
Exclusion
- Nausea-inducing disorder other than motion sickness
- BMI\>40
- History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists
Key Trial Info
Start Date :
November 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2023
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT04327661
Start Date
November 15 2021
End Date
April 12 2023
Last Update
December 11 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Pacific Research Network, LLC
San Diego, California, United States, 92103
2
Santa Monica Clinical Trials
Santa Monica, California, United States, 90025
3
Gulfcoast Psychiatric Associates
Fort Myers, Florida, United States, 33912
4
Harmony Clinical Research
North Miami Beach, Florida, United States, 33162